StonvexLoading…
StonvexStonvexStonvexCore line items from MXL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $467.64M | $360.53M | $693.26M | $1.12B |
Operating Income | $-126.89M | $-223.35M | $-38.22M | $180.24M |
Net Income | $-136.68M | $-245.20M | $-73.15M | $125.04M |
EPS (Diluted) | $-1.58 | $-2.93 | $-0.91 | $1.55 |
Total Assets | $796.40M | $864.64M | $1.08B | $1.18B |
Total Liabilities | $344.50M | $348.36M | $393.99M | $503.64M |
Cash & Equivalents | $72.81M | $118.58M | $187.29M | $187.35M |
Free Cash Flow OCF − CapEx | $7.02M | $-62.98M | $29.92M | $347.47M |
Shares Outstanding | 86.45M | 84.61M | 81.82M | 78.75M |